New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that pregnant women with Takayasu's arteritis, a type of large-vessel vasculitis, appear to have a high prevalence ...
Nov 2, 2021
0
1
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that people with difficult-to-treat rheumatoid arthritis who do not have success with one Janus kinase inhibitor ...
Nov 2, 2021
0
1
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, found that a virtual exercise program can be safe for people with musculoskeletal conditions, improved their health ...
Nov 2, 2021
0
1
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that in one study, the majority of rheumatoid arthritis patients on an ultra-low dose of the drug rituximab ...
Nov 2, 2021
0
5
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that the COVID-19 vaccine was not associated with severe disease flares in patients with rheumatic diseases. ...
Nov 1, 2021
0
2
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that use of platelet inhibitors could be associated with a reduction in the occurrence of digital ulcers, painful ...
Nov 1, 2021
0
2
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows a relationship between genotype, bone marrow failure and survival in patients with the rare autoinflammatory ...
Nov 1, 2021
0
3
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that biologics were the most common initial treatment prescribed to treat systemic juvenile idiopathic arthritis ...
Nov 1, 2021
0
2
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that higher doses, longer duration of use, chronic kidney disease and Asian race could all be independent risk ...
Nov 1, 2021
0
59
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that hydroxychloroquine, an antimalarial drug and mainstay therapy for lupus, does not appear to be associated ...
Nov 1, 2021
0
1
